Literature DB >> 7666564

cis-acting sequences involved in human immunodeficiency virus type 1 RNA packaging.

J F Kaye1, J H Richardson, A M Lever.   

Abstract

We have previously described a series of human immunodeficiency virus type 1-based vectors in which efficient RNA encapsidation appeared to correlate with the presence of a 1.1-kb env gene fragment encompassing the Rev-responsive element (RRE). In this report, we explore in detail the role of the RRE and flanking env sequences in vector expression and RNA encapsidation. The analysis of a new series of vectors containing deletions within the env fragment failed to identify a discrete packaging signal, although the loss of certain sequences reduced packaging efficiency three- to fourfold. Complete removal of the env fragment resulted in a 100-fold decrease in the vector transduction titer but did not abolish RNA encapsidation. We conclude that the RRE and 3' env sequences are not essential for human immunodeficiency virus type 1 vector encapsidation but may be important in vectors in which a heterologous gene has been placed adjacent to the 5' packaging signal, potentially disrupting its structure.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7666564      PMCID: PMC189565     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology.

Authors:  F Clavel; J M Orenstein
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus.

Authors:  A Aldovini; R A Young
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

3.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

Authors:  P J Maddon; A G Dalgleish; J S McDougal; P R Clapham; R A Weiss; R Axel
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

4.  Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector.

Authors:  T Shimada; H Fujii; H Mitsuya; A W Nienhuis
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

5.  Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.

Authors:  S Schwartz; B K Felber; G N Pavlakis
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

6.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.

Authors:  J P Morgenstern; H Land
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

7.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

8.  Human immunodeficiency virus vectors for inducible expression of foreign genes.

Authors:  G L Buchschacher; A T Panganiban
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

9.  Gene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vector.

Authors:  M Poznansky; A Lever; L Bergeron; W Haseltine; J Sodroski
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

10.  Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions.

Authors:  A Lever; H Gottlinger; W Haseltine; J Sodroski
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

View more
  27 in total

Review 1.  Lentiviral vector-mediated RNA silencing in the central nervous system.

Authors:  Thomas H Hutson; Edmund Foster; Lawrence D F Moon; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther Methods       Date:  2013-11-01       Impact factor: 2.396

2.  Functional analysis of the core human immunodeficiency virus type 1 packaging signal in a permissive cell line.

Authors:  G P Harrison; G Miele; E Hunter; A M Lever
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

3.  The role of nucleocapsid and U5 stem/A-rich loop sequences in tRNA(3Lys) genomic placement and initiation of reverse transcription in human immunodeficiency virus type 1.

Authors:  Y Huang; A Khorchid; J Gabor; J Wang; X Li; J L Darlix; M A Wainberg; L Kleiman
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Position dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivo.

Authors:  M S McBride; A T Panganiban
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation.

Authors:  M S McBride; M D Schwartz; A T Panganiban
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

6.  RNA structure and packaging signals in the 5' leader region of the human immunodeficiency virus type 1 genome.

Authors:  Jared L Clever; Daniel Miranda; Tristram G Parslow
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

7.  Mapping the encapsidation determinants of feline immunodeficiency virus.

Authors:  Iris Kemler; Roman Barraza; Eric M Poeschla
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

8.  The major human immunodeficiency virus type 2 (HIV-2) packaging signal is present on all HIV-2 RNA species: cotranslational RNA encapsidation and limitation of Gag protein confer specificity.

Authors:  S D Griffin; J F Allen; A M Lever
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

9.  Construction and molecular analysis of gene transfer systems derived from bovine immunodeficiency virus.

Authors:  R Berkowitz; H Ilves; W Y Lin; K Eckert; A Coward; S Tamaki; G Veres; I Plavec
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

10.  Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation.

Authors:  J F Kaye; A M Lever
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.